CASPeR Ranking #38
ITI Pharma and Healthcare Fund Regular Growth
NAV (Wed Dec 04 2024)
₹17
Returns (Since Inception)
20.79%
Category Average
20.56%
Rating
NA
Allocation and Holdings
Asset class
Weightage
Healthcare
54.95%
Get your personalized mutual fund portfolio in 2 minutes.
4.5Overall rating
Scheme Information
Fund name
ITI Pharma and Healthcare Fund Regular Growth
Minimum SIP
500
Risk Level
Very High Risk
AUM
₹208.21 Cr
ISIN
INF00XX01BL5
Inception Date
Nov 11 2021
Standard Deviation
15.076
Beta
0.88
Sharpe Ratio
0.903
Benchmark
NIFTY Healthcare TR TR INR
Expense Ratio
2.350%
Exit Load
1% - If redeemed or switched out on or before completion of 12 months from the date of allotment of units. Nil - If redeemed or switched out after completion of 12 months from the date of allotment of units.
Risk
Very High Risk
Investment Objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.
Fund Managers
Rohan Korde
Pratibh Agarwal
Hetal Gada
About the AMC
ITI Asset Management Limited
Phone Number
022-66214999Email Address
mfassist@itiorg.comCorporate Office Address
Naman Midtown “A” Wing, 21st Floor, Senapati Bapat Marg, Elphinstone RoadOverall AUM
₹208.21 Cr
Website
www.itimf.com
Popular Equity funds
View all Funds
Franklin India Equity Advantage Fund Direct Growth
₹3517.97 Cr
15.85%
SBI PSU Regular Growth
₹4471.14 Cr
37.49%
Nippon India ELSS Tax Saver Fund Direct Plan - Growth Option
₹15673.23 Cr
20.04%
Nippon India Multi Cap Fund - Direct Plan - Growth
₹38677.71 Cr
27.96%
Quant Focused fund Growth Option Direct Plan
₹1120.71 Cr
19.43%
Expert designed mutual fund portfolios
Mutual Funds are a smart way to grow your money. They can help you achieve your financial goals as they have the potential to generate higher-than-inflation returns.
subscribe to The Sunday Investor & impress
your coworkers with your finance insights
no promotions • no spam • only finance
